Modalities
Comprehensive End-to-End Solutions
- Discovery & Development
- CMC - Manufacturing
- CMC-Quality Control
- Preclinical Studies
- Clinical Studies
Cell Culture Products
CAR Target Proteins
Universal CAR Detection Tool
MHC-peptide Complexes
ComboX: Streptavidin (SA) Series
Aneuro: Proteins for Neuroscience
GMP-grade Growth Factors
Extracellular Matrix (ECM) Proteins
Serum-free Cell Culture Medium
Disposable Accessories
Cell Activation
Gene Editing
CAR Target Proteins
Anti-Linker Antibodies
Safety Testing Platform
CMC Residue Detection Kits
Flow Cytometry Analysis Platform
Antibody Density Detection on Carriers
Our Commitment
ACROBiosystems' Core Brand Values
- QUALITY
- INNOVATION
- SERVICE
Certified Excellence
Rigorous Testing
Regulatory Filings
Stringent Verification
Audit Ready
Expert Led
As we prepare for an international multicentric controlled Phase 3 study evaluating the safety and efficacy of ProtheraCytes in post-acute myocardial infarction patients, we chose ACROBiosystems GMP proteins for their level of documentation, quality control, and regulatory compliance to meet our future commercialization demands.
QUALITY Customer Story
Ibon Garitaonandia, Ph.D., MBA
Chief Scientific Officer, CellProthera
Our Global Reach
Dedicated Local Support, Always on Standby
- Offices
- R&D Centers
- Manufacturing Bases
- Logistics Hubs
London, United Kingdom
Frankfurt, Germany
Paris, France
Basel, Switzerland
Boston, MA, USA
Newark, DE, USA
San Diego, CA, USA
Beijing, China
Seoul, South Korea
Nanjing, China
Suzhou, China
Shanghai, China
Tokyo, Japan
Hangzhou, China
Hong Kong, China
San Jose, CA, USA
Customers
Locations
Employees
- Events
- Activities
North America
ISSCR Annual Meeting 2026
Learn MoreEurope
The 10th Bioproduction Congress 2025
Learn MoreAsia Pacific
